PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Research and Educational Center of the M. V. Lomonosov Moscow State University, Moscow, Russia Faculty of Fundamental Medicine, Lomonosov Moscow State University, Russia.\', \'Medical Research and Educational Center of the M. V. Lomonosov Moscow State University, Moscow, Russia.\', \'National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia Robertson Centre for Biostatistics, Glasgow, Great Britain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.18087/cardio.2020.9.n1338
?:hasPublicationType
?:journal
  • Kardiologiia
is ?:pmid of
?:pmid
?:pmid
  • 33131470
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • [Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)].
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all